Literature DB >> 29272979

Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases.

Monika Gudowska-Sawczuk1, Alicja Wrona2, Ewa Gruszewska1, Bogdan Cylwik2, Anatol Panasiuk3, Robert Flisiak3, Lech Chrostek1.   

Abstract

INTRODUCTION: The aim of this study was to evaluate the concentration of interleukin-6 and N-terminal propeptide of procollagen type I and their relationship in liver diseases of different etiologies.
MATERIAL AND METHODS: Serum samples were obtained from 30 healthy volunteers and patients suffering from alcoholic cirrhosis (AC) - 31, non-alcoholic cirrhosis (NAC) - 28 and toxic hepatitis (HT) - 23 patients. Cirrhotic patients were classified according to Child-Pugh score. IL-6 and PINP concentrations were determined according to the electrochemiluminescence immunoassay.
RESULTS: The mean serum IL-6 concentration was significantly higher in AC (mean ± SD:21.52 ± 15.01 pg/mL), NAC (20.07 ± 32.12 pg/mL) and HT (15.14 ± 17.18 pg/mL) when compared to the control group (C) (1.67 ± 0.42 pg/mL) (Mann-Whitney U test: p < .001 for all comparisons). The mean serum PINP concentration was significantly higher only in patients with AC (104.32 ± 54.50 ng/mL) in comparison with the control group (54.70 ± 19.83 ng/mL; p < .001). The mean values of IL-6 and PINP significantly differed between liver diseases (ANOVA rank Kruskal-Wallis test: p = .020 and p < .001, respectively). Accordingly, the serum levels of IL-6 and PINP were significantly higher in patients with AC than that in NAC (p < .001 and p = .022, respectively). IL-6 and PINP concentrations appeared to vary depending on the severity of liver damage (p < .001 for both). The concentrations of IL-6 and PINP were significantly higher in class C (31.88 ± 21.51 pg/mL; 132.73 ± 65.63 ng/mL, respectively) than that in class A (6.12 ± 9.00 pg/mL; 57.32 ± 28.85 ng/mL, respectively) (p < .001 for both). There were also significant differences in IL-6 concentrations between Child-Pugh class B (27.88 ± 24.45 pg/mL) and class A (6.12 ± 9.00 pg/mL; p < .001).
CONCLUSIONS: We conclude that serum concentrations of IL-6 and PINP change in liver diseases, and those changes reflect the severity of liver disease.

Entities:  

Keywords:  Interleukin-6; N-terminal propeptide of procollagen type I; biomarkers; liver cirrhosis; toxic hepatitis

Mesh:

Substances:

Year:  2017        PMID: 29272979     DOI: 10.1080/00365513.2017.1420217

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Interleukin-6 gene polymorphisms and susceptibility to liver diseases: A meta-analysis.

Authors:  Xuehan Wang; Zhenghui Yan; Qingjian Ye
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

2.  Biliary Obstruction Promotes Multilineage Differentiation of Hepatic Stem Cells.

Authors:  Mladen I Yovchev; Edward J Lee; Waldemar Rodriguez-Silva; Joseph Locker; Michael Oertel
Journal:  Hepatol Commun       Date:  2019-05-23

3.  Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes.

Authors:  Ningjian Wang; Yuying Wang; Xiaoman Chen; Wen Zhang; Yi Chen; Fangzhen Xia; Heng Wan; Qing Li; Boren Jiang; Bin Hu; Yingli Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-28       Impact factor: 5.555

4.  Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis.

Authors:  Jixi Xu; Mingbo Li; Wei Pei; Jinyong Ding; Yueran Pan; Huifeng Peng; Shiman Lin; Yanbo Huang
Journal:  Genet Res (Camb)       Date:  2022-03-07       Impact factor: 1.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.